4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000899243-17-005429
CIK 0000891293operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:31 PM ET
Size
5.8 KB
Accession
0000899243-17-005429
Insider Transaction Report
Form 4
NUDELMAN PHILLIP M PHD
Director
Transactions
- Award
Stock Option (right to buy)
2017-02-23+50,000→ 50,000 totalExercise: $4.25Exp: 2027-02-22→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option was granted on February 23, 2017 and vests on the first to occur of (i) the date that is twelve months after the date of grant, (ii) the first annual meeting of CTIC's shareholders in 2018 at which one or more members of the CTIC Board of Directors are to be elected, or (iii) immediately prior to the occurrence of a Change of Control (as such term is defined in CTIC's 2015 Equity Incentive Plan), subject to the Reporting Persons' continued service through such date or event.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:31 PM ET
- Size
- 5.8 KB